Subcutaneous Monitoring and Delivery System with AI, IoT, and Blockchain Integration

Publication ID: 24-11857218_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Subcutaneous Monitoring and Delivery System with AI, IoT, and Blockchain Integration,” Published Technical Disclosure No. 24-11857218_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857218_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,218.

Summary of the Inventive Concept

A synergistic system integrating a subcutaneous monitoring device with AI, IoT, and blockchain technologies to provide real-time data analysis, remote patient monitoring, and secure data management, enabling more effective and personalized healthcare.

Background and Problem Solved

The original patent disclosed a subcutaneous delivery tool, but it lacked real-time data analysis, remote monitoring capabilities, and secure data management. This inventive concept addresses these limitations by integrating AI, IoT, and blockchain technologies to create a more comprehensive and connected healthcare system.

Detailed Description of the Inventive Concept

The system consists of a subcutaneous monitoring device integrated with an AI module for real-time data analysis and IoT connectivity for remote patient monitoring. The implantation device features a blockchain-secured platform for authenticating and tracking medical devices, ensuring secure data management. The subcutaneous delivery tool has a nanomaterial-coated surface for enhanced biocompatibility and an integrated AI-driven navigation system for precise device placement. The system also includes a decentralized blockchain network for storing and managing patient data, along with an AI-powered analytics module for identifying trends and patterns.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, and blockchain technologies, which are not obvious extensions of the original patent. The inventive step lies in combining these distinct technologies to create a more powerful and connected healthcare system.

Alternative Embodiments and Variations

Alternative embodiments may include variations in the AI module's architecture, the type of nanomaterial used for coating, or the specific blockchain protocol employed. Additionally, the system could be adapted for use in different medical applications, such as diabetes management or cardiovascular monitoring.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in remote patient monitoring, personalized medicine, and medical device development. The integration of AI, IoT, and blockchain technologies addresses pressing needs in healthcare, including data security, real-time analysis, and patient outcomes.

CPC Classifications

SectionClassGroup
A A61 A61B17/3468
A A61 A61B5/29
A A61 A61B17/32093
A A61 A61B2017/320044
A A61 A61B2017/320056
A A61 A61N1/3756
A A61 A61N1/37205

Field of Art

Medical Device Technology, specifically subcutaneous monitoring and delivery systems, involving biomedical engineering, sensor technologies, and minimally invasive medical instrumentation

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in implantable technologies, sensor integration, data transmission, and advanced medical instrumentation, holding advanced degrees and practical experience in developing minimally invasive medical monitoring systems

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies into existing subcutaneous monitoring devices represents a predictable technological evolution driven by contemporary trends in digital healthcare. The source patent's foundational subcutaneous delivery mechanism provides a clear technical framework for incorporating advanced digital technologies. The proposed variations represent logical extensions of existing medical device integration strategies that would be apparent to a skilled practitioner seeking to enhance monitoring capabilities and data management.

Obvious Combinations & Variations

Source Patent Element
Subcutaneous implantation device with channel for medical device placement
PTD Variation
Adding AI-driven navigation system for precise device placement
Obviousness Reasoning
Integrating sensor-based navigation is a known technique in medical device placement, representing a predictable improvement to existing implantation technologies
Source Patent Element
Medical monitoring device for subcutaneous parameter tracking
PTD Variation
Incorporating IoT connectivity and remote patient monitoring capabilities
Obviousness Reasoning
Extending medical devices with wireless communication is a standard design approach in contemporary medical technology, offering predictable enhancements to data collection and patient management
Source Patent Element
Subcutaneous delivery tool with basic material construction
PTD Variation
Implementing nanomaterial-coated surface for enhanced biocompatibility
Obviousness Reasoning
Material science improvements, particularly nanomaterial coatings, represent a known strategy for enhancing medical device performance and are considered routine design optimization
Source Patent Element
Medical device for parameter monitoring
PTD Variation
Blockchain-secured platform for device authentication and data management
Obviousness Reasoning
Implementing secure data management technologies is a predictable response to increasing cybersecurity requirements in medical device ecosystems
Source Patent Element
Subcutaneous monitoring mechanism
PTD Variation
Machine learning algorithms for predicting patient outcomes
Obviousness Reasoning
Applying predictive analytics to medical monitoring data represents a standard technological progression in data-driven healthcare technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857218 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed subcutaneous monitoring system with AI, IoT, and blockchain integration to be an obvious extension of existing medical device technologies. The combination of known elements produces no unexpected results and represents a predictable application of contemporary digital healthcare innovations to established subcutaneous monitoring methodologies.

Original Patent Information

Patent NumberUS 11,857,218
TitleSubcutaneous delivery tool
Assignee(s)Medtronic, Inc.